ANI Pharmaceuticals insider files Form 144 to sell 7,292 shares valued at $692,270

Rhea-AI Filing Summary

Form 144 notice for ANI Pharmaceuticals, Inc. (ANIP) reports a proposed sale of 7,292 shares of common stock through Morgan Stanley Smith Barney LLC on NASDAQ with an aggregate market value of $692,270.40 and stated approximate sale date of 09/03/2025. The filer identifies prior restricted stock acquisitions of 3,000 shares on 04/27/2023 and 4,292 shares on 03/23/2022, both received from the issuer, and discloses a sale during the past three months of 5,421 shares for $486,406.81 on 08/20/2025. The form includes the standard representation that the seller is not aware of any undisclosed material adverse information.

Insights

Securities Analyst

TL;DR: Insider sale disclosed; transaction size is small relative to total shares outstanding and appears routine.

The filing notifies the market of a planned sale of 7,292 common shares through Morgan Stanley Smith Barney with an indicated value of $692,270.40 and references recent restricted stock grants and a recent sale of 5,421 shares generating $486,406.81. With 21,688,772 shares outstanding, the planned sale represents roughly 0.03% of outstanding shares, suggesting limited immediate dilution or market impact. The disclosure is consistent with Rule 144 mechanics for restricted securities and includes the standard attestation about undisclosed material information.

Corporate Governance Expert

TL;DR: Document fulfills disclosure obligations under Rule 144; provides dates and amounts for grants and recent sales.

The filer documents acquisition dates for restricted stock awards and lists a broker and planned sale date, meeting procedural requirements for public notice of proposed insider sales. The filing contains the prescribed representation regarding material nonpublic information and highlights a recent sale within the last three months. There are no statements here about changes in management, related-party issues, or other governance events; thus the filing appears to be a routine transparency disclosure rather than a governance red flag.

FAQ

What insider sale does ANIP's Form 144 disclose?

The form discloses a proposed sale of 7,292 shares of ANIP common stock through Morgan Stanley Smith Barney with an aggregate market value of $692,270.40 and an approximate sale date of 09/03/2025.

What recent sales by the filer are reported in the past three months for ANIP?

The filing reports a sale on 08/20/2025 of 5,421 shares of common stock for gross proceeds of $486,406.81.

How many ANIP shares outstanding are shown on the Form 144?

The form indicates 21,688,772 shares of common stock outstanding.

When were the restricted stock grants acquired by the filer?

The filer received 4,292 shares as restricted stock on 03/23/2022 and 3,000 shares on 04/27/2023, both from the issuer.

Which broker is handling the proposed ANIP share sale?

The broker named on the form is Morgan Stanley Smith Barney LLC, Executive Financial Services, 1 New York Plaza, 8th Floor, New York, NY 10004.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 09/03/2025 - 04:03 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	7292	692270.40	21688772	09/03/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/27/2023	Restricted Stock	Issuer			3000	04/27/2023	Not Applicable
Common	03/23/2022	Restricted Stock	Issuer			4292	03/23/2022	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ANTONIO R PERA 210 Main Street West Baudette MN 56623	Common	08/20/2025	5421	486406.81

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)